美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
33342-276-07	33342-276	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20170729	N/A	ANDA	ANDA207302	Macleods Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-276-07)
33342-276-10	33342-276	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20170729	N/A	ANDA	ANDA207302	Macleods Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-276-10)
33342-276-12	33342-276	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20170729	N/A	ANDA	ANDA207302	Macleods Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	7.5 mg/1	10 BLISTER PACK in 1 CARTON (33342-276-12) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
33342-277-07	33342-277	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20170729	N/A	ANDA	ANDA207302	Macleods Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-277-07)
33342-277-10	33342-277	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20170729	N/A	ANDA	ANDA207302	Macleods Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-277-10)
33342-277-12	33342-277	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin	TABLET, EXTENDED RELEASE	ORAL	20170729	N/A	ANDA	ANDA207302	Macleods Pharmaceuticals Limited	DARIFENACIN HYDROBROMIDE	15 mg/1	10 BLISTER PACK in 1 CARTON (33342-277-12) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK